173 related articles for article (PubMed ID: 27067689)
1. [A Case of Minimally Invasive Apocrine Carcinoma Derived from Ductal Adenoma].
Moro K; Koyama Y; Nagahashi M; Hasegawa M; Toshikawa C; Tsuchida J; Hanyu T; Ishikawa T; Shimada Y; Sakata J; Kameyama H; Kobayashi T; Minagawa M; Kosugi S; Kato T; Watanabe G; Ajioka Y; Wakai T
Gan To Kagaku Ryoho; 2016 Feb; 43(2):235-7. PubMed ID: 27067689
[TBL] [Abstract][Full Text] [Related]
2. The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma in situ.
Hung WK; Ying M; Chan M; Mak KL; Chan LK
Breast Cancer; 2010 Oct; 17(4):276-80. PubMed ID: 19756924
[TBL] [Abstract][Full Text] [Related]
3. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
[TBL] [Abstract][Full Text] [Related]
4. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
[TBL] [Abstract][Full Text] [Related]
5. Can additional histopathological examination of ultrasound-guided axillary lymph node core biopsies improve preoperative diagnosis of primary breast cancer nodal metastasis?
Mullen R; Purdie CA; Jordan LB; McLean D; Whelehan P; Vinnicombe S; Brown DC; Evans A
Clin Radiol; 2013 Jul; 68(7):704-7. PubMed ID: 23518495
[TBL] [Abstract][Full Text] [Related]
6. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
Chin-Lenn L; Mack LA; Temple W; Cherniak W; Quinn RR; Ravani P; Lewin AM; Quan ML
Ann Surg Oncol; 2014 Jan; 21(1):66-73. PubMed ID: 24046105
[TBL] [Abstract][Full Text] [Related]
7. Ductal carcinoma in situ with isolated tumor cells in the sentinel lymph node in a 17-year-old adolescent girl.
Sato T; Muto I; Hasegawa M; Aono T; Sakai T; Oya T
Breast Cancer; 2013 Jul; 20(3):271-4. PubMed ID: 20411367
[TBL] [Abstract][Full Text] [Related]
8. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.
Han JS; Molberg KH; Sarode V
Breast J; 2011; 17(3):223-9. PubMed ID: 21545433
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
Zhang JG; Zhong L; Li CL
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
[No Abstract] [Full Text] [Related]
10. Occult "micrometastases" in ductal carcinoma in situ: investigative implications for sentinel lymph node biopsy.
Weaver DL
Cancer; 2003 Nov; 98(10):2083-7. PubMed ID: 14601075
[No Abstract] [Full Text] [Related]
11. [Ductal carcinoma in situ of the breast with microinvasion. Role of sentinel lymph node biopsy].
Le Bouëdec G; de Lapasse C; Mishellany F; Chêne G; Michy T; Gimbergues P; Dauplat J
Gynecol Obstet Fertil; 2007 Apr; 35(4):317-22. PubMed ID: 17344087
[TBL] [Abstract][Full Text] [Related]
12. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
Park HS; Park S; Cho J; Park JM; Kim SI; Park BW
J Surg Oncol; 2013 Mar; 107(4):388-92. PubMed ID: 23007901
[TBL] [Abstract][Full Text] [Related]
13. The role of sentinel node biopsy in ductal carcinoma in situ of the breast.
Polom K; Murawa D; Wasiewicz J; Nowakowski W; Murawa P
Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312
[TBL] [Abstract][Full Text] [Related]
14. [Predictive factors of invasion with initial diagnosis of ductal carcinoma in situ based on core biopsy].
Kósa C; Garami Z; Dinya T; Fülöp B
Magy Seb; 2012 Aug; 65(4):218-21. PubMed ID: 22940391
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy for breast cancer: indications, contraindications, and new directions.
Cody HS
J Surg Oncol; 2007 May; 95(6):440-2. PubMed ID: 17458860
[No Abstract] [Full Text] [Related]
16. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY
Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854
[TBL] [Abstract][Full Text] [Related]
17. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
Cox CE; Nguyen K; Gray RJ; Salud C; Ku NN; Dupont E; Hutson L; Peltz E; Whitehead G; Reintgen D; Cantor A
Am Surg; 2001 Jun; 67(6):513-9; discussion 519-21. PubMed ID: 11409797
[TBL] [Abstract][Full Text] [Related]
18. Synchronous ductal carcinoma in situ of the breast and within epithelial inclusions in an ipsilateral sentinel lymph node.
Fitzpatrick-Swallow VL; Helin H; Cane P; Pinder SE
Hum Pathol; 2013 Jan; 44(1):142-4. PubMed ID: 23089490
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy in patients with pure and high-risk ductal carcinoma in situ of the breast.
D'Eredità G; Giardina C; Napoli A; Ingravallo G; Troilo VL; Fischetti F; Berardi T
Tumori; 2009; 95(6):706-11. PubMed ID: 20210234
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy?
Murthy V; Chamberlain RS
Clin Breast Cancer; 2013 Jun; 13(3):180-7. PubMed ID: 23357305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
